The FDA approved a pulmonary embolism device to be made by Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI) sending the stock price soaring 65 cents to $2.35.
FDA Approves Angiotech's Pulmonary Embolism Device
June 08, 2009 at 13:25 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.